Weekly News Recap #Phispers
Sanofi, Roche, Sobi, Avantor – a big week for M&As; JAK inhibitors to carry heart safety, cancer warnings
This week, Phispers brings you news on Pfizer’s Xeljanz, which underwent a post-approval study. Post the study, the ...
Impressions : 2244
AstraZeneca’s shareholders rebel over CEO pay; FDA lashes out at IQVIA over erroneous data
Soon after
US President Donald Trump revealed his new drug pricing plan, the FDA took a
tough stand by releasing a list of dr...
Impressions : 5179
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.